A matching-adjusted indirect treatment comparison (MAIC) of daratumumab–bortezomib–melphalan–prednisone (D-VMP) versus lenalidomide–dexamethasone continuous (Rd continuous), lenalidomide–dexamethasone 18 months (Rd 18), and melphalan–prednisone–thalidomide (MPT)

1. Dimopoulos, M.A.
2. Cavo, M.
3. Mateos, M.-V.
4. Facon, T.
5. Heeg, B.
6. van Beekhuizen, S.
7. Gebregergish, S.B.
8. Nair, S.
9. Pisini, M.
10. Lam, A.
11. Slavcev, M.